Compass Pathways (FRA:5Y6) FFO


FRA:5Y6 Compass Pathways PLC FRA:5Y6
40 GF Score
Price €12.70
! 2 Warning Signs
View Full Analysis

What is Compass Pathways FFO?

FFO (Funds from operations) only applies to REITs.

FRA:5Y6
40GF Score
Compass Pathways PLC FRA:5Y6
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Compass Pathways Business Description

Address 33 Broadwick Street, London, GBR, W1F 0DQ
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
40GF Score

Get the complete analysis for FRA:5Y6

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.70
Price